Literature DB >> 1893937

Evidence for a role of the monoclonal antibody E48 defined antigen in cell-cell adhesion in squamous epithelia and head and neck squamous cell carcinoma.

A H Schrijvers1, M Gerretsen, J M Fritz, M van Walsum, J J Quak, G B Snow, G A van Dongen.   

Abstract

Monoclonal antibody (MAb) E48 recognizes a 20- to 22-kDa antigen expressed by human squamous and transitional epithelia and their neoplastic counterparts. Histochemical examination of these tissues revealed distinct surface labeling with MAb E48. To investigate the subcellular localization of the E48 antigen we have performed electron microscopical analysis. In cells of normal oral mucosa, the E48 antigen was expressed on the plasmalemma, particularly associated with desmosomes, suggesting involvement of the E48 antigen in intercellular adhesion. Furthermore, the level of expression of the E48 antigen appeared to be influenced by the cellular organization. In squamous cell carcinoma (SCC) cell lines grown in vitro as subconfluent monolayer cultures, the E48 antigen expression was low. However, E48 antigen expression increased when SCC cells were grown to confluency. E48 antigen expression was similarly high when SCC cell lines were cultured under conditions promoting three-dimensional growth either as colonies within floating collagen gels or as xenograft in tumor-bearing nude mice. Further evidence for the involvement of the E48 antigen in cell-cell adhesion was found when SCC cells were grown within collagen gels in the presence of MAb E48: no spherical colonies were formed, but cells grew out to colonies composed of single cells. Moreover, in this culture system the percentage of SCC cells growing out to colonies was decreased by the presence of MAb E48. These findings indicate that the E48 antigen is involved in the structural organization of squamous tissue and might have a role in intercellular adhesion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1893937     DOI: 10.1016/0014-4827(91)90260-2

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

1.  Cloning and characterization of a human LYPD7, a new member of the Ly-6 superfamily.

Authors:  Jun Ni; Qingyu Lang; Meirong Bai; Chaomin Zhong; Xinya Chen; Bo Wan; Long Yu
Journal:  Mol Biol Rep       Date:  2008-03-24       Impact factor: 2.316

2.  Selective expression of murine prostate stem cell antigen in fetal and adult tissues and the transgenic adenocarcinoma of the mouse prostate model of prostate carcinogenesis.

Authors:  S Ross; S D Spencer; L A Lasky; H Koeppen
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Genetic reprogramming of tumor cells by zinc finger transcription factors.

Authors:  Pilar Blancafort; Emily I Chen; Beatriz Gonzalez; Sharon Bergquist; Andries Zijlstra; Daniel Guthy; Arndt Brachat; Ruud H Brakenhoff; James P Quigley; Dirk Erdmann; Carlos F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

4.  Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts.

Authors:  D C Saffran; A B Raitano; R S Hubert; O N Witte; R E Reiter; A Jakobovits
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 5.  Current perspectives in the use of monoclonal antibodies for detection and treatment of head and neck tumors.

Authors:  J Quak; G van Dongen
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

Review 6.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

7.  Use of monoclonal antibody E48 in diagnosing transitional cell carcinoma of urinary bladder.

Authors:  R Torenbeek; C E Blomjous; J J Quak; S Ybema; C J Meijer
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

8.  Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer.

Authors:  R H Brakenhoff; F B van Gog; J E Looney; M van Walsum; G B Snow; G A van Dongen
Journal:  Cancer Immunol Immunother       Date:  1995-03       Impact factor: 6.968

9.  Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors.

Authors:  Willi Jugel; Achim Aigner; Susanne Michen; Alexander Hagstotz; Alexander Ewe; Dietmar Appelhans; Gabriele Schackert; Achim Temme; Stefanie Tietze
Journal:  Pharmaceutics       Date:  2021-05-08       Impact factor: 6.321

10.  Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.

Authors:  M Gerretsen; A H Schrijvers; M van Walsum; B J Braakhuis; J J Quak; C J Meijer; G B Snow; G A van Dongen
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.